血清尿酸と高密度の脂質タンパク質コレステロールの比率と心不全との関連:横断的な研究
Zhujun Fang1, Zhijie Jiang1, Xiaojuan Wang1
1Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.
BMC cardiovascular disorders
|August 29, 2025
まとめ
血清尿酸と高密度の脂質タンパク質コレステロール (UHR) の比率は,心不全 (HF) と関連しています. より高いUHRレベルはHFのリスクを高め,バイオマーカーとしての可能性を示唆しています.
科学分野:
- 心臓病科
- 代謝 健康
- バイオマーカーの研究
背景:
- 心不全 (HF) は代謝障害と密接に関連しています.
- 血清尿酸と高密度の脂質タンパク質コレステロール (UHR) の比率は,認知された炎症および代謝マーカーです.
- UHRとHFのリスクの間の特定の関連は,さらなる解明を必要とします.
研究 の 目的:
- 血清のUHRと心不全 (HF) の罹患率との関係を調査する.
- HFリスク評価のための複合バイオマーカーとしてのUHRの可能性を評価する.
主な方法:
- NHANES (2003年−2018年) の28,169人の参加者を対象とした横断的な研究.
- ロジスティック回帰分析 (単変数および多変数) とサブグループ分析が行われました.
- UHRとHFの非線形関係を評価するために,制限された立方スライン分析を使用した.
主要な成果:
- 混同因子 (OR=1. 82) を調整した結果,LnUHRとHFの間の正の相関が認められた.
- 高いLnUHRレベル (Q4対Q1) は,HFのリスクの増加と関連していました (OR=1. 71).
- ほとんどのサブグループで安定した関連が観察され,ポジティブな非線形傾向と5. 52の転換点が見られました.
結論:
- LnUHRは心不全 (HF) と正に関連していることが確認されています.
- LnUHRは,HFの複合バイオマーカーとしての可能性を示しています.
- 発見を検証し,メカニズムを探求するために,さらなる大規模な見通し研究が必要である.
関連する概念動画
Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
Blood Studies for Cardiovascular System III: Serum Lipid Profile
291
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
291
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Hazard Ratio
241
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
241
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23


